PMI R&D to Revenue
Picard Medical, Inc. Common Stock · R&D to Revenue
PMI R&D to Revenue
Latest reported60.73%period ending
PMI FY R&D/Revenue (46.24% → 60.73%)
Latest values, visible window
High-resolution chart · PNG
PMI r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 60.7287% | |
| 76.9756% | |
| 43.8826% | |
| 46.2436% |